Walgreens Was Not Following COVID-19 Dose Timing Guidelines
TUESDAY, April 6, 2021 -- Walgreens was not following U.S. government guidance on when to give second doses of COVID-19 vaccines but will start doing so after hearing from the U.S. Centers for Disease Control and Prevention.
The pharmacy chain has given the two-dose Pfizer vaccine to thousands of people but was giving the two doses four weeks apart instead of the recommended three weeks, The New York Times reported.
Walgreens said it was giving the doses four weeks apart because it made it simpler and faster to schedule appointments. But some customers were confused by the company's policy, which was brought to the attention of the CDC. The agency asked Walgreens to use the recommended three-week period between doses, according to CDC spokeswoman Kate Grusich.
There is no evidence that the vaccine is less effective if people go four weeks before receiving their second dose, The Times reported. While it recommends the three-week gap, the CDC says it is acceptable to go up to six weeks between doses of the vaccine.

© 2021 HealthDay. All rights reserved.
Posted: April 2021
Further Support and Information on COVID-19
Read this next
Blood Type Not Associated With COVID-19 Outcomes
FRIDAY, April 9, 2021 -- Blood type is not associated with COVID-19 susceptibility or outcomes, according to a research letter published online April 5 in JAMA Network...
Antibodies Persist Six Months After Second Dose of Moderna COVID-19 Vaccine
FRIDAY, April 9, 2021 -- Antibodies persist through six months after the second dose of the Moderna COVID-19 mRNA vaccine, according to a letter to the editor published online...
Mortality Risk Up for Dialysis Patients in March to July 2020
FRIDAY, April 9, 2021 -- Patients undergoing dialysis and those with kidney transplants had increased mortality risk in 2020 compared with 2017 to 2019, according to a study...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.